The invention provides an isolated nucleic acid encoding an antibody or an antigen-binding fragment thereof, wherein the antibody or antigen-binding fragment thereof binds to human C5 and C5a, and wherein the antibody is a chimeric, deimmunized or humanized form of monoclonal antibody 137-26 produced by the hybridoma deposited with the ATCC and designated PTA-3650.